The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 2, 2003, Pages 159-177

  Arnold, Robyn E ^a   Weigent, Douglas A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

CYP2E1; Growth hormone; Lymphocytes; Superoxide

Indexed keywords

4 NITROPHENOL; 7 ETHOXY 4 TRIFLUOROMETHYLCOUMARIN; ALLOPURINOL; ALLYL SULFIDE; COUMARIN DERIVATIVE; CYTOCHROME P450 2E1; GROWTH HORMONE; ISONIAZID; N(G) METHYLARGININE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUOROMETRY; IMMUNOBLOTTING; LYMPHOCYTE; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2E1; ENZYME INHIBITORS; FLOW CYTOMETRY; FLUOROMETRY; GROWTH HORMONE; ISONIAZID; LYMPHOMA, T-CELL; MICE; NADPH OXIDASE; OMEGA-N-METHYLARGININE; SUPEROXIDES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; XANTHINE OXIDASE;

ANIMALIA;

EID: 0037570766     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120020467     Document Type: Article

References (64)

1. Weigent, D.A.; Blalock, J.E. The production of growth hormone by subpopulations of rat mononuclear leukocytes. Cell Immunol. 1991, 135, 55-65.
2. Lincoln, D.T.; Sinowatz, F.; Temmim-Baker, L.; Baker, H.I.; Kolle, S.; Waters, M.J. Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem. Cell Biol. 1998, 109, 141-159.
3. Hull, K.L.; Thiagarajah, A.; Harvey, S. Cellular localization of growth hormone receptors/binding proteins in immune tissues. Cell Tissue Res. 1996, 286, 69-80.
4. Lytras, A.; Quan, N.; Vrontakis, M.E.; Shaw, J.E.; Cattini, P.A.; Friesen, H.G. Growth hormone expression in human Burkitt lymphoma serum-free Ramos cell line. Endocrinology 1993, 132, 620-628.
5. Rohn, W.M.; Weigent, D.A. Cloning and nucleotide sequencing of rat lymphocyte growth hormone cDNA. Neuroimmunomodulation 1995, 2, 108-114.
6. Seeburg, P.H.; Shine, J.; Martial, J.; Baxter, J.D.; Goodman, H.M. Nucleotide sequence and amplification in bacteria of a structural gene to rat GH. Nature 1977, 270, 486-494.
7. Weigent, D.A.; Baxter, J.B.; Wear, W.E.; Smith, L.R.; Bost, K.L.; Blalock, J.E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 1988, 2, 2812-2818.
8. Hattori, N.; Shimatsu, A.; Sugita, M.; Kumagai, S.; Imura, H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem. Biophys. Res. Commun. 1990, 168, 396-401.
9. Varma, S.; Sabharwal, P.; Sheridan, J.F.; Malarkey, W.B. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J. Clin. Endocrinol. Metab. 1993, 76, 49-53.
10. Malarkey, W.B.; Wang, J.; Cheney, C.; Glaser, R.; Hagaraja, H. Human lymphocyte growth hormone stimulates interferon gamma production and is inhibited by cortisol and norepinephrine. J. Neuroimmunol. 2002, 123, 180-187.
11. Kao, T.L.; Supowit, S.C.; Thompson, E.A.; Meyer, W.J., III. Immunoreactive growth hormone production by human lymphocyte cell lines. Cell Mol. Neurobiol. 1992, 12, 483-498.
12. Weigent, D.A. Immunoregulatory properties of growth hormone and prolactin. J. Pharmacol. Therapeut. 1996, 69, 237-257.
13. Van Buul-Offers, S.C.; Kooijman, R. The role of GH and insulin-like growth factors in the immune system. Cell Mol. Life Sci. 1998, 54, 1083-1094.
14. Rapaport, R.; Oleske, J.; Ahdieh, H.; Skuza, K.; Holland, B.K.; Passannante, M.R.; Denny, T. Effects of human growth hormone on immune functions: in vitro studies on cells of normal and growth hormone-deficient children. Life Sci. 1987, 41, 2319-2324.
15. Baroni, C.D.; Fabris, N.; Bertoli, G. Effects of hormones on development and function of lymphoid tissues. Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice. J. Immunol. 1969, 17, 303-314.
16. Snow, E.C.; Feldbush, T.L.; Oaks, J.A. The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. J. Immunol. 1981, 126, 161-164.
17. Mercola, K.E.; Cline, M.J.; Golde, D.W. Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood 1981, 58, 337-340.
18. Berczi, I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation 1994, 1, 201-216.
19. Schimpff, R.M.; Repellin, A.M. Production of interleukin-1-alpha and interleukin-2 by mononuclear cells in healthy adults in relation to different experimental conditions and to the presence of growth hormone. Hormone Res. 1990, 33, 171-176.
20. Mellado, M.; Llorente, M.; Rodriguez-Frade, M.; Lucas, P.; Martinez, A.C.; delReal, G. HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone. Vaccine 1998, 15, 1111-1115.
21. Wiedermann, C.J.; Reinisch, N.; Kahler, C.; Geisen, F.; Zilian, U.; Herold, M.; Braunsteiner, H. In vivo activation of circulating monocytes by exogenous growth hormone in man. Brain Behav. Immun. 1992, 6, 387-393.
22. Yoshida, A.; Ishioka, C.; Kimota, H.; Mikawa, H. Recombinant human growth hormone stimulates B-cell immunoglobulin synthesis and proliferation in serum-free medium. Endocrin 1992, 126, 524-529.
23. Weigent, D.A.; Blalock, J.E.; LeBoeuf, R.D. An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology 1991, 128, 2053-2057.
24. Baxter, J.B.; Blalock, J.E.; Weigent, D.A. Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 1991, 129, 1727-1734.
25. Niandong, L.; Hichem, C.; Mertani, C.N.G.; Tornell, J.; Lobie, P.E. Mode of the autocrine/paracrine mechanism of growth hormone action. Exp. Cell. Res. 1997, 237, 196-206.
26. 2O2. J. Immunol. 1995, 154, 1909-1918.
27. Spadoni, G.L.; Spagnoli, A.; Cianfarani, S.; DelPrincipe, D.; Menichelli, A.; DiGiulio, S.; Boscherini, B. Enhancement by growth hormone of phorbol diesterstimulated respiratory burst in human polymorphonuclear leukocytes. Acta Endocrinologica 1991, 124, 589-594.
28. Fu, Y.K.; Arkins, S.; Wang, B.S.; Kelley, K.W. A novel role of growth hormone and insulin-like growth factor: priming neutrophils for superoxide anion secretion. J. Immunol. 1991, 146, 1602-1608.
29. Wiedermann, C.J.; Niedermühlbichler, M.; Geissler, D.; Beimpold, H.; Braunsteiner, H. Priming of normal human neutrophils by recombinant human growth hormone. Br. J. Haematol. 1991, 78, 19-22.
30. 2+ during growth hormone-induced priming of human neutrophils. Brain Behav. Immun. 1997, 11, 39-46.
31. Kamata, H.; Hirata, H. Redox regulation of cellular signalling. Cell Signal 1999, 11, 1-14.
32. Raucy, J.L.; Ingelman-Sundberg, M.; Carpenter, S.; Rannug, A.; Rane, A.; Franklin, M.; Romkes, M. Drug metabolizing enzymes in lymphocytes. J. Biochem. Mol. Toxicol. 1999, 13, 223-226.
33. Dey, A.; Parmer, D.; Dayal, M.; Dhawan, A.; Seth, P. Cytochrome P450 1A1 (cyp 1A1) in blood lymphocytes evidence for catalytic activity and mRNA expression. Life Sci. 2001, 69, 383-393.
34. Carcillo, J.; Parise, R.; Adedoyin, A.; Frye, R.; Branch, R.; Ramkes, M. Cyp 2D6 mRNA expression in circulating peripheral blood mononuclear cells correlates with in vivo debrisoguine hydroxylase activity in extensive metabolizers. Res. Commun. Mol. Pathol. Pharmacol. 1996, 91, 149-159.
35. Soh, Y.; Rhee, H.; Sohn, D.; Song, B. Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting. Biochem. Biophys. Res. Commun. 1996, 227, 541-546.
36. Diefenbach, A.; Bogdan, C.; Rollinghoff, M. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 2000, 12, 64-76.
37. Finkel, T. Signal transduction by reactive oxygen species in non-phagocytic cells. J. Leuk. Biol. 1999, 65, 337-340.
38. Pap, S.; Skulacter, V.P. Reactive oxygen species, mitochondria, apoptosis and aging. Mol. Cell Biochem. 1997, 174, 305-319.
39. Chen, Q.; Cedarbaum, A. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol. Pharmacol. 1998, 53, 638-648.
40. VanEngeland, M.; Nieland, L.J.W.; Ramaekers, F.C.S.; Schulte, B.; Reutelingsperger, C.P.M. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998, 31, 1-9.
41. Kobaik, L.; Godleski, J.J.; Brain, J.D. Oxidative metabolism in the alveolar macrophage: analysis by flow cytometry. J. Leuk. Biol. 1990, 47, 295-303.
42. Babior, B.M. NADPH oxidase: an update. Blood 1999, 5, 1464-1476.
43. Jones, O.T.G.; Wood, J.D. Oxidant production by B-lymphocytes: detection of activity and identification of components involved. Methods 1996, 9, 619-627.
44. Kalsi, J.K.; Clay, K.; Rickard, D.; Hall, N.D. Suppressive effects of a novel anti-oxidant compound on human T-cell functions in vitro. Agents Actions 1993, 39, C110-C112.
45. Kia, M.; Ilich, P.; Dempski, R.; Hille, R. Recent mechanistic studies of Xanthine oxidase. Biochem. Soc. Trans. 1997, 25, 768-773.
46. Song, B.J. Ethanol-inducible cytochrome P450 (CYP2E1): Biochemistry, molecular biology and clinical relevance: 1996 update. Alcholism Clin. Exp. Res. 1996, 20, 138A-146A.
47. Yang, C.S.; Chhabra, S.K.; Hong, J.Y.; Smith, T.J. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J. Nutr. 2001, 131, 1041S-1045S.
48. Haggerty, H.G.; Kim, B.S.; Holsapple, M.P. Characterization of the effects of direct alkylators on in vitro immune responses. Mutat. Res. 1990, 242, 67-78.
49. Tanaka, E.; Terada, M.; Misawa, S. Cytochrome P450 2E1: its clinical and toxicological role. J. Clin. Pharm. Ther. 2000, 25, 165-175.
50. Jones, S.M.; Boobis, A.R.; Moore, G.E.; Stanier, P. Expression of CYP 2E1 in human fetal and adult liver samples. Biochem. Pharm. 1992, 43, 1876-1879.
51. Carpenter, S.P.; Lasker, J.M.; Raucy, J.L. Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP 2E1) in human fetal liver and hepatocytes. Mol. Pharm. 1996, 49, 260-268.
52. Gergel, D.; Misik, V.; Riesz, P.; Cederbaum, A.L. Inhibition of rat and human cytochrome P450 2E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch. Biochem. Biophys. 1997, 337, 239-250.
53. Minamiyama, Y.; Takemura, S.; Imaoka, S.; Funae, Y.; Tanimoto, Y.; Inoue, M. Irreversible inhibition of cytochrome P450 by nitric oxide. J. Pharm. Exp. Ther. 1997, 283, 1479-1485.
54. Arnold, R.E.; Weigent, D.A. The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. J. Neuroimmunol. 2002, 134, 82-94.
55. Zhou, Y.; Xu, B.C.; Maheshwari, H.G.; He, L.; Reed, M.; Lozykowski, M.; Okada, S.; Cataldo, L.; Coschigamo, K.; Wagner, T.E.; Baumann, G.; Kopchick, J.J. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. USA 1997, 94, 13215-13220.
56. Murphy, W.J.; Hofmeister, R.; Durum, S.K. Bigger is better: studies on the thymus of dwarf mice. Int Symp of GH in Immune Reconstitution: Basic and Clinical Studies; 1999; 10.
57. Dobashi, H.; Sato, M.; Tanaka, T.; Tokuda, M.; Ishida, T. Growth hormone restores glucocorticoid-induced T cell suppression. FASEB J. 2001, 15, 1861-1863.
58. Takagi, K.; Suzuki, F.; Barrow, R.E.; Wolf, S.E.; Herndon, D.N. Recombinant human growth hormone modulates Thl and Th2 cytokine response in burned mice. Ann. Surg. 1998, 228, 106-111.
59. Yamashita, N.; Hashimoto, Y.; Honjo, M.; Yamashita, N. The effect of growth hormone on the proliferation of human Th cell clones. Life Sci. 2000, 66, 1929-1935.
60. Griffin, J.M.; Gilbert, K.M.; Pumford, N.R. Inhibition of CYP 2E1 reverses CD4 + T cell alterations in trichloroethylene-treated MRL +/+ mice. Toxicol. Sci. 2000, 54, 384-389.
61. Haas, C.; Ryffel, B.; LeHIr, M. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MLR/IPR mice. J. Immunol. 1999, 158, 5484-5491.
62. Jin, L.; Baillie, T.A. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chem. Res. Toxicol. 1997, 10, 318-327.
63. Mates, J.M.; Sanchez-Jimenez, F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci. 1999, 4, D339-D345.
64. Acner, E.S.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 2000, 267, 6102-6109.